Vischer advises AMR Action Fund on its investment in BioVersys

As we have informed here, the AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antimicrobials, has invested in BioVersys, a clinical-stage company based in Basel, Switzerland.

The transaction marks the Fund’s first investment in Europe and is an important step toward building an international portfolio of companies that are de-veloping urgently needed antimicrobials. BioVersys is focusing on research and develop-ment of therapies for life-threatening multidrug-resistant bacterial infections and targeted mi-crobiome modulation. With this investment, BioVersys extended its Series C investment round to CHF 32.6m.

VISCHER has advised AMR Action Fund with a team lead by partner Matthias Staehelin (pictured) with Sebastian Flückiger, Balthasar Müller and Natacha Tang (all corporate/m&a).

Vischer advises AMR Action Fund on its investment in BioVersys


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram